577O PRINCE: Interim analysis of the phase Ib study of 177Lu-PSMA-617 in combination with pembrolizumab for metastatic castration resistant prostate cancer (mCRPC)

Shahneen Sandhu, Anthony M. Joshua, Louise Emmett, Lavinia Spain, Lisa G. Horvath, Megan Crumbaker, A. Antón, Roslyn Wallace, Anupama Pasam, Mathias Bressel, Eoin Cassidy, Patricia Banks, Aravind Ravi Kumar, Ramin Alipour, Timothy Akhurst, Grace Kong, Ian D. Davis, Scott Williams, Rodney J. Hicks, Michael S. Hofman